Tacrolimus Binding Proteins
"Tacrolimus Binding Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of immunophilin proteins that bind to the immunosuppressive drugs TACROLIMUS (also known as FK506) and SIROLIMUS. EC 5.2.1.-
Descriptor ID |
D022021
|
MeSH Number(s) |
D08.811.399.325.500.400.700 D12.776.543.750.705.400.700 D12.776.827.275.700
|
Concept/Terms |
Tacrolimus Binding Proteins- Tacrolimus Binding Proteins
- FK506 Binding Protein
- FK506-Binding Protein
- Protein, FK506-Binding
- FKBP Rotamase
- Rotamase, FKBP
- FK506 Binding Proteins
- FK-506-Binding Protein
- FK 506 Binding Protein
- Protein, FK-506-Binding
- FKBP
Rapamycin Binding Proteins- Rapamycin Binding Proteins
- Binding Proteins, Rapamycin
- Rapamycin-Binding Proteins
- Proteins, Rapamycin-Binding
|
Below are MeSH descriptors whose meaning is more general than "Tacrolimus Binding Proteins".
Below are MeSH descriptors whose meaning is more specific than "Tacrolimus Binding Proteins".
This graph shows the total number of publications written about "Tacrolimus Binding Proteins" by people in this website by year, and whether "Tacrolimus Binding Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 0 | 1 | 1 |
1998 | 0 | 2 | 2 |
1999 | 0 | 1 | 1 |
2002 | 0 | 3 | 3 |
2003 | 1 | 2 | 3 |
2004 | 2 | 3 | 5 |
2005 | 1 | 2 | 3 |
2006 | 3 | 0 | 3 |
2007 | 2 | 2 | 4 |
2008 | 3 | 1 | 4 |
2010 | 0 | 2 | 2 |
2011 | 3 | 0 | 3 |
2012 | 1 | 2 | 3 |
2013 | 1 | 0 | 1 |
2014 | 3 | 0 | 3 |
2015 | 1 | 1 | 2 |
2016 | 0 | 1 | 1 |
2017 | 2 | 1 | 3 |
2018 | 0 | 1 | 1 |
2020 | 1 | 0 | 1 |
2021 | 1 | 0 | 1 |
2022 | 0 | 1 | 1 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Tacrolimus Binding Proteins" by people in Profiles.
-
Genetic variants, neurocognitive outcomes, and functional neuroimaging in survivors of childhood acute lymphoblastic leukemia. JNCI Cancer Spectr. 2023 07 03; 7(4).
-
FKBP5 inhibitors modulate alcohol drinking and trauma-related behaviors in a model of comorbid post-traumatic stress and alcohol use disorder. Neuropsychopharmacology. 2023 07; 48(8):1144-1154.
-
Localized chondro-ossification underlies joint dysfunction and motor deficits in the Fkbp10 mouse model of osteogenesis imperfecta. Proc Natl Acad Sci U S A. 2021 06 22; 118(25).
-
FKBP8 variants are risk factors for spina bifida. Hum Mol Genet. 2020 11 04; 29(18):3132-3144.
-
DNA methylation levels are associated with CRF1 receptor antagonist treatment outcome in women with post-traumatic stress disorder. Clin Epigenetics. 2018 11 03; 10(1):136.
-
Attachment style moderates effects of FKBP5 polymorphisms and childhood abuse on post-traumatic stress symptoms: Results from the National Health and Resilience in Veterans Study. World J Biol Psychiatry. 2019 04; 20(4):289-300.
-
FKBP65-dependent peptidyl-prolyl isomerase activity potentiates the lysyl hydroxylase 2-driven collagen cross-link switch. Sci Rep. 2017 04 05; 7:46021.
-
Fkbp10 Deletion in Osteoblasts Leads to Qualitative Defects in Bone. J Bone Miner Res. 2017 Jun; 32(6):1354-1367.
-
CaMKII-dependent phosphorylation of RyR2 promotes targetable pathological RyR2 conformational shift. J Mol Cell Cardiol. 2016 09; 98:62-72.
-
FKBP51 employs both scaffold and isomerase functions to promote NF-?B activation in melanoma. Nucleic Acids Res. 2015 Aug 18; 43(14):6983-93.